 |
Previous Article | Next Article 
The Journal of Neuroscience, May 15, 2002, 22(10):3977-3986
TrkB Gene Transfer Protects Retinal Ganglion Cells from
Axotomy-Induced Death In Vivo
Li
Cheng1,
Przemyslaw
Sapieha1,
Pavla
Kittlerová2,
William W.
Hauswirth3, and
Adriana
Di
Polo1
1 Department of Pathology and Cell Biology,
Université de Montréal, Montreal, Quebec H3T 1J4, Canada,
2 Montreal General Hospital Research Institute, McGill
University, Montreal, Quebec H3G 1A4, Canada, and
3 Department of Ophthalmology and Powell Gene Therapy
Center, University of Florida, Gainesville, FL 32610-0284
Injury-induced downregulation of neurotrophin receptors may limit
the response of neurons to trophic factors, compromising their ability
to survive. We tested this hypothesis in a model of CNS injury: retinal
ganglion cell (RGC) death after transection of the adult rat optic
nerve. TrkB mRNA rapidly decreased in axotomized RGCs to ~50%
of the level in intact retinas. TrkB gene transfer into RGCs combined
with exogenous BDNF administration markedly increased neuronal
survival: 76% of RGCs remained alive at 2 weeks after axotomy, a time
when >90% of these neurons are lost without treatment. Activation of
mitogen-activated protein kinase, but not phosphatidylinositol-3
kinase, was required for TrkB-induced survival. These data provide
proof-of-principle that enhancing the capacity of injured neurons to
respond to trophic factors can be an effective neuroprotective strategy
in the adult CNS.
Key words:
retinal ganglion cells; axotomy; gene transfer; TrkB; MAP
kinase; cell survival
Copyright © 2002 Society for Neuroscience 0270-6474/02/22103977-10$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
A. J. Weber, C. D. Harman, and S. Viswanathan
Effects of optic nerve injury, glaucoma, and neuroprotection on the survival, structure, and function of ganglion cells in the mammalian retina
J. Physiol.,
September 15, 2008;
586(18):
4393 - 4400.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Munemasa, S. H. Kim, J. H. Ahn, J. M. K. Kwong, J. Caprioli, and N. Piri
Protective Effect of Thioredoxins 1 and 2 in Retinal Ganglion Cells after Optic Nerve Transection and Oxidative Stress
Invest. Ophthalmol. Vis. Sci.,
August 1, 2008;
49(8):
3535 - 3543.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Weber and C. D. Harman
BDNF Preserves the Dendritic Morphology of {alpha} and {beta} Ganglion Cells in the Cat Retina after Optic Nerve Injury
Invest. Ophthalmol. Vis. Sci.,
June 1, 2008;
49(6):
2456 - 2463.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Pernet and A. Di Polo
Synergistic action of brain-derived neurotrophic factor and lens injury promotes retinal ganglion cell survival, but leads to optic nerve dystrophy in vivo
Brain,
April 1, 2006;
129(4):
1014 - 1026.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Mayor-Torroglosa, P. De la Villa, M. E. Rodriguez, M. P. L. Lopez-Herrera, M. Aviles-Trigueros, A. Garcia-Aviles, J. Miralles de Imperial, M. P. Villegas-Perez, and M. Vidal-Sanz
Ischemia Results 3 Months Later in Altered ERG, Degeneration of Inner Layers, and Deafferented Tectum: Neuroprotection with Brimonidine
Invest. Ophthalmol. Vis. Sci.,
October 1, 2005;
46(10):
3825 - 3835.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Gauthier, S. Joly, V. Pernet, P. Lachapelle, and A. Di Polo
Brain-Derived Neurotrophic Factor Gene Delivery to Muller Glia Preserves Structure and Function of Light-Damaged Photoreceptors
Invest. Ophthalmol. Vis. Sci.,
September 1, 2005;
46(9):
3383 - 3392.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Shevtsova, J. M. I. Malik, U. Michel, M. Bahr, and S. Kugler
Promoters and serotypes: targeting of adeno-associated virus vectors for gene transfer in the rat central nervous system in vitro and in vivo
Exp Physiol,
January 1, 2005;
90(1):
53 - 59.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Fischer, V. Petkova, S. Thanos, and L. I. Benowitz
Switching Mature Retinal Ganglion Cells to a Robust Growth State In Vivo: Gene Expression and Synergy with RhoA Inactivation
J. Neurosci.,
October 6, 2004;
24(40):
8726 - 8740.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Fischer, Z. He, and L. I. Benowitz
Counteracting the Nogo Receptor Enhances Optic Nerve Regeneration If Retinal Ganglion Cells Are in an Active Growth State
J. Neurosci.,
February 18, 2004;
24(7):
1646 - 1651.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. G. Martin, H. A. Quigley, D. J. Zack, H. Levkovitch-Verbin, J. Kielczewski, D. Valenta, L. Baumrind, M. E. Pease, R. L. Klein, and W. W. Hauswirth
Gene Therapy with Brain-Derived Neurotrophic Factor As a Protection: Retinal Ganglion Cells in a Rat Glaucoma Model
Invest. Ophthalmol. Vis. Sci.,
October 1, 2003;
44(10):
4357 - 4365.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Garcia, V. Forster, D. Hicks, and E. Vecino
In Vivo Expression of Neurotrophins and Neurotrophin Receptors Is Conserved in Adult Porcine Retina In Vitro
Invest. Ophthalmol. Vis. Sci.,
October 1, 2003;
44(10):
4532 - 4541.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Caleo, P. Medini, C. S. von Bartheld, and L. Maffei
Provision of Brain-Derived Neurotrophic Factor via Anterograde Transport from the Eye Preserves the Physiological Responses of Axotomized Geniculate Neurons
J. Neurosci.,
January 1, 2003;
23(1):
287 - 296.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Borras, C. R. Brandt, R. Nickells, and R. Ritch
Gene Therapy for Glaucoma: Treating a Multifaceted, Chronic Disease
Invest. Ophthalmol. Vis. Sci.,
August 1, 2002;
43(8):
2513 - 2518.
[Full Text]
[PDF]
|
 |
|
|